A disease-free survival rate for people receiving a bone marrow transplant to treat acute myeloid leukemia is between 45 and 60 percent, according to the National Cancer Institute. However, reported disease-free survival rates after a bone marrow transplant to treat leukemia vary considerably from study to study.
One factor affecting the estimated rate is whether the transplant used material from a compatible donor, explains the National Cancer Institute. Use of transplants from siblings results in the best survival rates, while experimental transplants from unrelated individuals have disease-free survival rates of 35 percent. People over the age of 50 also have a higher rate of mortality after a bone marrow transplant procedure than those younger than 50.